Glioblastoma (GBM) is the most common and lethal tumor of the central nervous system. The
natural history of treated GBM remains very poor with 5-year survival rates of 5%. Survival …

Glioblastoma, the most common and most rapidly progressing primary malignant tumor of
the central nervous system, continues to portend a dismal prognosis, despite improvements …

Purpose To investigate whether radiomic features at MRI improve survival prediction in
patients with glioblastoma multiforme (GBM) when they are integrated with clinical and …

Precision medicine in cancer proposes that genomic characterization of tumors can inform
personalized targeted therapies,,,,. However, this proposition is complicated by spatial and …

Brain metastasis (BM) is one of the main complications of many cancers, and the most
frequent malignancy of the central nervous system. Imaging studies of BMs are routinely …

Purpose To evaluate the prognostic and predictive value of surface-derived imaging
biomarkers obtained from contrast material–enhanced volumetric T1-weighted pretreatment …

Purpose: Radiomics is the extraction of multidimensional imaging features, which when
correlated with genomics, is termed radiogenomics. However, radiogenomic biological …

Simple Summary Glioblastoma (GBM) is the most malignant primary brain tumor, for which
improving patient outcome is limited by a substantial amount of tumor heterogeneity …

Background Glioblastoma (GBM) tumors exhibit strong phenotypic differences that can be
quantified using magnetic resonance imaging (MRI), but the underlying biological drivers of …

Malignant gliomas are primary brain tumours with an infiltrative growth pattern, often with
contrast enhancement on magnetic resonance imaging (MRI). However, it is well known that …